David M Lubman Selected Research

Collodion (Nitrocellulose)

1/2010	The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line.
6/2009	The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray.
4/2008	Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot.
7/2003	Protein microarrays using liquid phase fractionation of cell lysates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David M Lubman Research Topics

Disease

48	Neoplasms (Cancer) 01/2020 - 04/2002
22	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 07/2006
20	Fibrosis (Cirrhosis) 07/2022 - 04/2008
14	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 06/2014
11	Breast Neoplasms (Breast Cancer) 01/2017 - 11/2003
10	Chronic Pancreatitis 04/2015 - 09/2006
9	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 04/2002
8	Neoplasm Metastasis (Metastasis) 01/2017 - 09/2004
8	Adenocarcinoma 01/2017 - 08/2004
7	Glioblastoma (Glioblastoma Multiforme) 02/2015 - 05/2010
5	Non-alcoholic Fatty Liver Disease 07/2022 - 01/2020
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 06/2014
5	Carcinoma (Carcinomatosis) 03/2009 - 04/2002
4	Liver Diseases (Liver Disease) 01/2021 - 06/2014
4	Melanoma (Melanoma, Malignant) 06/2011 - 11/2010
2	Colonic Neoplasms (Colon Cancer) 10/2016 - 05/2003
2	Colorectal Neoplasms (Colorectal Cancer) 10/2016 - 04/2008
2	Pancreatitis 04/2014 - 06/2008
2	Urinary Bladder Neoplasms (Bladder Cancer) 05/2011 - 07/2007
2	Inflammation (Inflammations) 01/2011 - 03/2008
2	Endometrioid Carcinoma 04/2009 - 01/2006
2	Disease Progression 01/2009 - 12/2008
2	Prostatic Neoplasms (Prostate Cancer) 03/2008 - 07/2003
1	Body Weight (Weight, Body) 01/2021
1	Alcoholic Hepatitis 01/2021
1	Fatty Liver 01/2021
1	Obesity 01/2021
1	Liver Neoplasms (Liver Cancer) 10/2020
1	Pediatric Crohn's disease 01/2019
1	Glioma (Gliomas) 02/2015
1	Ovarian Epithelial Carcinoma 01/2015
1	Cysts 04/2014
1	Carcinogenesis 04/2014
1	Obstructive Jaundice (Cholestatic Jaundice) 04/2014

Drug/Important Bio-Agent (IBA)

60	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2002
40	Biomarkers (Surrogate Marker)IBA 07/2022 - 07/2003
28	Glycoproteins (Glycoprotein)IBA 01/2022 - 07/2006
16	LectinsIBA 10/2020 - 07/2006
13	HaptoglobinsIBA 07/2022 - 05/2007
13	Polysaccharides (Glycans)IBA 10/2020 - 07/2006
10	Peptides (Polypeptides)IBA 01/2022 - 09/2002
9	GlycopeptidesIBA 07/2022 - 07/2006
8	Blood Proteins (Serum Proteins)IBA 01/2022 - 01/2009
5	AutoantibodiesIBA 01/2011 - 03/2008
4	Amino Acids FDA Link 01/2020 - 12/2014
4	ProteomeIBA 01/2019 - 08/2004
4	Collodion (Nitrocellulose)IBA 01/2010 - 07/2003
3	AntigensIBA 07/2022 - 03/2008
3	histidine-rich proteinsIBA 09/2012 - 04/2008
3	Tumor Biomarkers (Tumor Markers)IBA 06/2011 - 08/2004
2	Ceruloplasmin (Ferroxidase)IBA 01/2022 - 06/2014
2	ApolipoproteinsIBA 01/2021 - 08/2007
2	CateninsIBA 10/2016 - 03/2008
2	Leucine (L-Leucine)FDA Link 01/2015 - 07/2013
2	HemopexinIBA 07/2013 - 05/2007
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 12/2011 - 10/2011
2	AntibodiesIBA 01/2011 - 01/2010
2	PhosphoproteinsIBA 06/2010 - 02/2006
2	AgglutininsIBA 05/2010 - 07/2006
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 05/2010 - 10/2008
2	Lamin Type A (Lamin A)IBA 03/2009 - 06/2007
2	Biological ProductsIBA 07/2007 - 05/2007
2	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 05/2007 - 07/2006
2	Pharmaceutical PreparationsIBA 03/2004 - 05/2003
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 07/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2020
1	acarboxyprothrombin (PIVKA)IBA 10/2020
1	Sepharose (Agarose)IBA 01/2020
1	ImmunosorbentsIBA 01/2019
1	AcidsIBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	EnzymesIBA 01/2019
1	TrypsinIBA 01/2019
1	Gemcitabine FDA Link 01/2018
1	Phenol (Carbolic Acid)FDA Link 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	AminesIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2017
1	Epithelial Cell Adhesion MoleculeIBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	AnnexinsIBA 01/2017
1	antineoplaston A10 (A 10)IBA 01/2017
1	Fibronectins (Fibronectin)IBA 11/2015
1	TenascinIBA 02/2015
1	Transferrin (beta 2 Transferrin)IBA 12/2014
1	ClusterinIBA 07/2013
1	SialoglycoproteinsIBA 07/2013
1	Vitamin D-Binding ProteinIBA 07/2013

Therapy/Procedure

8	Therapeutics 10/2018 - 03/2004
3	Lasers (Laser) 06/2013 - 09/2002
2	Immunotherapy 01/2020 - 03/2012
2	Drug Therapy (Chemotherapy) 01/2018 - 10/2016
2	Radiotherapy 04/2012 - 06/2011
1	Bariatric Surgery 01/2021
1	Chemoradiotherapy 01/2017
1	Chemoprevention 01/2016